Sleep fragmentation engages stress-responsive circuitry, enhances inflammation and compromises hippocampal function following traumatic brain injury.

HPA-axis Neuroinflammation Schaffer collateral Sleep fragmentation Stress Traumatic brain injury fear conditioning glucocorticoid receptor hippocampus

Journal

Experimental neurology
ISSN: 1090-2430
Titre abrégé: Exp Neurol
Pays: United States
ID NLM: 0370712

Informations de publication

Date de publication:
07 2022
Historique:
received: 31 08 2021
revised: 04 03 2022
accepted: 24 03 2022
pubmed: 1 4 2022
medline: 4 5 2022
entrez: 31 3 2022
Statut: ppublish

Résumé

Traumatic brain injury (TBI) impairs the ability to restore homeostasis in response to stress, indicating hypothalamic-pituitary-adrenal (HPA)-axis dysfunction. Many stressors result in sleep disturbances, thus mechanical sleep fragmentation (SF) provides a physiologically relevant approach to study the effects of stress after injury. We hypothesize SF stress engages the dysregulated HPA-axis after TBI to exacerbate post-injury neuroinflammation and compromise recovery. To test this, male and female mice were given moderate lateral fluid percussion TBI or sham-injury and left undisturbed or exposed to daily, transient SF for 7- or 30-days post-injury (DPI). Post-TBI SF increases cortical expression of interferon- and stress-associated genes characterized by inhibition of the upstream regulator NR3C1 that encodes glucocorticoid receptor (GR). Moreover, post-TBI SF increases neuronal activity in the hippocampus, a key intersection of the stress-immune axes. By 30 DPI, TBI SF enhances cortical microgliosis and increases expression of pro-inflammatory glial signaling genes characterized by persistent inhibition of the NR3C1 upstream regulator. Within the hippocampus, post-TBI SF exaggerates microgliosis and decreases CA1 neuronal activity. Downstream of the hippocampus, post-injury SF suppresses neuronal activity in the hypothalamic paraventricular nucleus indicating decreased HPA-axis reactivity. Direct application of GR agonist, dexamethasone, to the CA1 at 30 DPI increases GR activity in TBI animals, but not sham animals, indicating differential GR-mediated hippocampal action. Electrophysiological assessment revealed TBI and SF induces deficits in Schaffer collateral long-term potentiation associated with impaired acquisition of trace fear conditioning, reflecting dorsal hippocampal-dependent cognitive deficits. Together these data demonstrate that post-injury SF engages the dysfunctional post-injury HPA-axis, enhances inflammation, and compromises hippocampal function. Therefore, external stressors that disrupt sleep have an integral role in mediating outcome after brain injury.

Identifiants

pubmed: 35358498
pii: S0014-4886(22)00083-8
doi: 10.1016/j.expneurol.2022.114058
pmc: PMC9068267
mid: NIHMS1795384
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114058

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS118037
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS112805
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG051902
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS109585
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS105864
Pays : United States
Organisme : NIDCR NIH HHS
ID : T32 DE014320
Pays : United States
Organisme : NINDS NIH HHS
ID : F31 NS122471
Pays : United States
Organisme : NINDS NIH HHS
ID : P30 NS045758
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

J Neurotrauma. 2013 Aug 15;30(16):1426-33
pubmed: 23470214
J Neurosci. 2004 Nov 24;24(47):10594-602
pubmed: 15564575
Brain Inj. 2002 Mar;16(3):197-206
pubmed: 11874613
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3919-24
pubmed: 10760263
J Clin Endocrinol Metab. 2004 Oct;89(10):4929-36
pubmed: 15472187
Brain Behav Immun. 2010 Oct;24(7):1202-8
pubmed: 20382217
Neuropathol Appl Neurobiol. 2013 Oct;39(6):654-66
pubmed: 23231074
Mol Psychiatry. 2021 Sep;26(9):4770-4782
pubmed: 32444870
Exp Neurol. 2016 Mar;277:227-243
pubmed: 26730521
Biochem Pharmacol. 2010 Dec 15;80(12):2009-20
pubmed: 20599425
Sleep Med. 2006 Sep;7(6):486-97
pubmed: 16934524
Brain Res. 2001 Aug 17;911(1):22-6
pubmed: 11489440
Acta Neuropathol. 2003 May;105(5):420-4
pubmed: 12677441
J Neurophysiol. 2012 Jun;107(12):3397-408
pubmed: 22442572
Front Neuroendocrinol. 2003 Jul;24(3):151-80
pubmed: 14596810
Transl Stroke Res. 2013 Dec;4(6):685-92
pubmed: 24323422
Front Immunol. 2019 Aug 07;10:1859
pubmed: 31440248
Neuroscience. 2019 Jul 15;411:237-254
pubmed: 31146008
Psychoneuroendocrinology. 2019 Apr;102:248-255
pubmed: 30594817
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3630-3639
pubmed: 30020469
Hippocampus. 1992 Oct;2(4):421-30
pubmed: 1308198
J Neurotrauma. 2008 Apr;25(4):311-23
pubmed: 18373481
Neurosci Lett. 2009 May 29;456(1):20-4
pubmed: 19429126
J Neurosci. 2020 Mar 11;40(11):2357-2370
pubmed: 32029532
Neuroscience. 2012 May 17;210:393-402
pubmed: 22445725
Prog Neurobiol. 2005 Feb;75(2):143-60
pubmed: 15784304
Nat Rev Neurosci. 2009 Jun;10(6):397-409
pubmed: 19469025
IUBMB Life. 2009 Oct;61(10):979-86
pubmed: 19787703
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7397-402
pubmed: 19376972
J Neurosci. 1989 Sep;9(9):3072-82
pubmed: 2795152
PLoS One. 2014 May 15;9(5):e97689
pubmed: 24831808
Behav Neurosci. 2003 Oct;117(5):1044-53
pubmed: 14570553
BMC Neurosci. 2014 Dec 04;15:130
pubmed: 25472829
J Neurosci. 2013 Oct 2;33(40):15669-74
pubmed: 24089474
Glia. 2018 Dec;66(12):2719-2736
pubmed: 30378170
Neural Regen Res. 2020 Jul;15(7):1259-1265
pubmed: 31960811
Sleep. 2018 Oct 1;41(10):
pubmed: 30053263
Hippocampus. 2006;16(2):103-13
pubmed: 16261555
Brain Behav Immun. 2018 Jul;71:9-17
pubmed: 29601944
Semin Immunol. 2017 Oct;33:30-36
pubmed: 29042026
Hippocampus. 2005;15(4):418-26
pubmed: 15669102
Stress. 2004 Dec;7(4):221-31
pubmed: 16019587
Cell Rep. 2020 Feb 25;30(8):2758-2775.e6
pubmed: 32101750
J Neuroinflammation. 2011 Jul 06;8:79
pubmed: 21733175
J Neurosci. 2008 Jun 18;28(25):6383-7
pubmed: 18562608
Comp Med. 2013 Apr;63(2):91-104
pubmed: 23582416
Mol Psychiatry. 2018 Jun;23(6):1421-1431
pubmed: 28373688
Biol Psychiatry. 2019 Apr 15;85(8):679-689
pubmed: 30447911
Int J Mol Sci. 2020 Jan 08;21(2):
pubmed: 31936248
Neurobiol Dis. 2006 Jun;22(3):453-62
pubmed: 16530419
Biol Psychiatry. 2014 Oct 1;76(7):575-84
pubmed: 24289885
Hippocampus. 2007;17(5):338-48
pubmed: 17315197
J Biol Chem. 2001 Jun 29;276(26):23382-90
pubmed: 11303025
Front Neurosci. 2020 Jul 28;14:756
pubmed: 32848547
Sleep. 2017 Oct 1;40(10):
pubmed: 28958055
Behav Neurosci. 1996 Dec;110(6):1321-34
pubmed: 8986335
Braz J Med Biol Res. 2012 Apr;45(4):292-8
pubmed: 22450375
Front Immunol. 2018 Nov 20;9:2622
pubmed: 30515152
Nat Neurosci. 2002 Feb;5(2):162-8
pubmed: 11780144
Brain Inj. 1999 Dec;13(12):1005-15
pubmed: 10628505
Brain Res. 2001 Dec 20;922(2):250-60
pubmed: 11743957
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
J Neurotrauma. 2015 Jan 15;32(2):127-38
pubmed: 25070744
Psychoneuroendocrinology. 2017 Mar;77:284-294
pubmed: 28135675
J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):150-7
pubmed: 18304804
J Neurotrauma. 2006 Dec;23(12):1802-13
pubmed: 17184190
Ann Neurol. 2011 Sep;70(3):374-83
pubmed: 21710619
Trends Neurosci. 2015 Oct;38(10):609-620
pubmed: 26442695
Front Neurol. 2019 Apr 24;10:345
pubmed: 31068886
Brain Res. 2009 Jan 16;1249:43-53
pubmed: 19007760
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16574-9
pubmed: 24062448
Brain Commun. 2019 Oct 21;1(1):fcz028
pubmed: 32954268
J Comp Neurol. 1993 Jun 1;332(1):1-20
pubmed: 7685778
Trends Neurosci. 2001 Sep;24(9):540-6
pubmed: 11506888
J Neuroinflammation. 2011 Jul 05;8:77
pubmed: 21729288
Immunity. 2019 Feb 19;50(2):317-333.e6
pubmed: 30683620
Science. 1999 Oct 22;286(5440):785-90
pubmed: 10531066
Front Behav Neurosci. 2019 May 29;13:116
pubmed: 31191269
J Biol Chem. 2006 Feb 10;281(6):3651-9
pubmed: 16339765
Mol Cell Biol. 2013 Aug;33(15):2879-90
pubmed: 23716595
J Sleep Res. 2018 Dec;27(6):e12710
pubmed: 29797753
Biol Psychiatry. 2010 Feb 1;67(3):199-207
pubmed: 19833323
Brain Behav Immun. 2016 May;54:95-109
pubmed: 26774527
J Neurotrauma. 2018 Jan 1;35(1):73-84
pubmed: 28859549
J Neurotrauma. 2016 Apr 1;33(7):625-40
pubmed: 26414955
Behav Brain Res. 2002 Jun 15;133(1):57-68
pubmed: 12048174
J Neurosci. 2020 Apr 1;40(14):2960-2974
pubmed: 32094203
J Neurosci. 2011 Jun 29;31(26):9683-95
pubmed: 21715634
J Neurochem. 2006 Nov;99(4):1263-72
pubmed: 16981890
Brain Behav Immun. 2021 Oct;97:423-439
pubmed: 34343616
Neuroscience. 2012 Aug 2;216:133-42
pubmed: 22554776
J Neurochem. 2016 Oct;139 Suppl 2:136-153
pubmed: 26990767
Brain Res. 1996 Sep 9;733(1):56-63
pubmed: 8891248
J Neurotrauma. 2020 Aug 15;37(16):1829-1843
pubmed: 32164485
Int J Mol Sci. 2019 Mar 16;20(6):
pubmed: 30884801
Glia. 2008 Apr 15;56(6):659-74
pubmed: 18286612
Brain Behav Immun. 2019 Oct;81:484-494
pubmed: 31279682
Brain Res Mol Brain Res. 2004 Dec 20;132(2):146-54
pubmed: 15582154
J Exp Med. 2016 Apr 4;213(4):585-603
pubmed: 27001747
J Neurosurg. 2018 Apr 1;:1-18
pubmed: 29701556
J Sleep Res. 2013 Feb;22(1):50-7
pubmed: 22835074
Neuroendocrinology. 1990 Mar;51(3):328-36
pubmed: 2157997
Mol Endocrinol. 2008 Aug;22(8):1754-66
pubmed: 18483179
J Head Trauma Rehabil. 2011 Sep-Oct;26(5):355-63
pubmed: 21169862
Neurobiol Aging. 2016 Aug;44:22-41
pubmed: 27318131
Alzheimers Res Ther. 2020 Apr 21;12(1):45
pubmed: 32317025
Mol Psychiatry. 2011 Dec;16(12):1177-88
pubmed: 21537331
J Neurosci Res. 1999 Oct 1;58(1):62-75
pubmed: 10491572
J Inflamm Res. 2018 Feb 12;11:49-60
pubmed: 29483781
Brain Res. 2000 Apr 7;861(1):69-76
pubmed: 10751566
Behav Sleep Med. 2007;5(4):256-78
pubmed: 17937582
J Neurotrauma. 2010 Jun;27(6):1081-9
pubmed: 20560754
Cell Stress Chaperones. 2017 Jul;22(4):653-663
pubmed: 28425051
J Neurophysiol. 2005 Nov;94(5):3479-86
pubmed: 16033944
J Neurotrauma. 2019 Mar 1;36(5):802-814
pubmed: 30136622
Oncotarget. 2018 Jan 04;9(14):11515-11527
pubmed: 29545916
Brain. 2013 Jan;136(Pt 1):28-42
pubmed: 23365092
Brain Res. 1985 Feb;350(1-2):169-73
pubmed: 3986611
Arch Phys Med Rehabil. 2014 May;95(5):986-995.e1
pubmed: 24462839
J Neurosci. 2010 Jul 14;30(28):9641-6
pubmed: 20631193
Sci Rep. 2016 Apr 13;6:23855
pubmed: 27073028
Neurosci Lett. 1998 Jun 19;249(2-3):123-6
pubmed: 9682832
Mol Psychiatry. 2021 Mar;26(3):888-896
pubmed: 31332262
Mol Psychiatry. 2014 Jul;19(7):811-22
pubmed: 24589888
J Neurotrauma. 2013 Jul 15;30(14):1250-6
pubmed: 23384619
Nature. 2020 Oct;586(7829):417-423
pubmed: 32999463
Front Cell Neurosci. 2018 Sep 27;12:323
pubmed: 30319362
Proc Natl Acad Sci U S A. 1984 Oct;81(19):6174-7
pubmed: 6592609
J Neurosci. 2021 Feb 17;41(7):1597-1616
pubmed: 33452227

Auteurs

Zoe M Tapp (ZM)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA. Electronic address: Zoe.tapp@osumc.edu.

Sydney Cornelius (S)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA. Electronic address: Cornelius.20@wright.edu.

Alexa Oberster (A)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA.

Julia E Kumar (JE)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA. Electronic address: Kumarje@mail.uc.edu.

Ravitej Atluri (R)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA. Electronic address: Ra939519@ohio.edu.

Kristina G Witcher (KG)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA. Electronic address: Kristina.Witcher@umm.edu.

Braedan Oliver (B)

Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA. Electronic address: Braedan.oliver@osumc.edu.

Chelsea Bray (C)

Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA. Electronic address: Chelsea.Bray@osumc.edu.

John Velasquez (J)

Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA. Electronic address: Jvelasq1@alumni.nd.edu.

Fangli Zhao (F)

Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA. Electronic address: Fangli.Zhao@osumc.edu.

Juan Peng (J)

Center for Biostatistics, The Ohio State University, 320-55 Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43210, USA. Electronic address: Juan.Peng@osumc.edu.

John Sheridan (J)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA; Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA; Division of Biosciences, College of Dentistry, The Ohio State University, 305 W. 12(th) Ave, Columbus, OH 43210, USA. Electronic address: John.Sheridan@osumc.edu.

Candice Askwith (C)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA. Electronic address: Candice.Askwith@osumc.edu.

Jonathan P Godbout (JP)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA; Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA. Electronic address: Jonathan.Godbout@osumc.edu.

Olga N Kokiko-Cochran (ON)

Dept. of Neuroscience, College of Medicine, The Ohio State University, 1858 Neil Ave, Columbus, OH 43210, USA; Institute for Behavioral Medicine Research, Neurological Institute, The Ohio State University, 460 Medical Center Drive, Columbus, OH 43210, USA. Electronic address: olga.kokiko-cochran@osumc.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH